CONTEXT: This review focuses on the prediction of recurrence and progression in non–
muscle invasive bladder cancer (NMIBC) and the treatments advocated for this disease …

Context The incidence of bladder cancer is three to four times greater in men than in women.
However, women are diagnosed with more advanced disease at presentation and have less …

Abstract Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and
has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour …

Small renal tumors are increasingly diagnosed and are frequently treated by nephron-
sparing surgery. Tumors can be ablated by radiofrequency (RF) energy, which allows the …

Abstract Background The European Association of Urology (EAU) prognostic factor risk
groups for non–muscle-invasive bladder cancer (NMIBC) are used to provide …

Background Renal tumor biopsy (RTB) for the characterization of small renal masses
(SRMs) has not been widely adopted despite reported safety and accuracy. Without …

Purpose Multidisciplinary management improves complex treatment decision making in
cancer care, but its impact for bladder cancer (BC) has not been documented. Although …

Background Substantial geographical differences in prostate cancer (PCa) incidence and
mortality exist, being lower among Asian (ASI) men compared with Caucasian (CAU) men …

Objectives: To evaluate the long–term effects of 3–month neoadjuvant hormonal treatment in
patients treated by radical prostatectomy for locally confined prostate cancer. Methods: We …

CONTEXT: Bladder cancer diagnosis and surveillance includes cystoscopy and cytology.
The limitation of urinary cytology is its low sensitivity for low-grade recurrences. As of now …